Addressing Challenges in Treatment of Growth Hormone Deficiency

To participate in this activity, please:

Growth hormone deficiency (GHD) is a complex disorder that can present in childhood or adulthood and results in growth failure along with more serious complications, including delayed bone age, increased adiposity, and systemic symptoms. This activity reviews the complex management of GHD, from diagnosis through treatment. The activity also reviews the wide array of established and novel recombinant growth hormone therapy options, including long-acting growth hormone treatments. Strategies for shared decision making are also discussed, along with recommendations for transitioning patients from pediatric to adult care.

Course Credit:

0.50 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2021-05-20
Closes: 2022-05-20

Target Audience:

This activity is intended for a national audience of pediatric and adult endocrinologists, pediatricians, and other clinicians involved in the management of patients with growth/growth hormone deficiencies.

This activity is supported by an educational grant from Ascendis Pharma, Inc.

    Presenting Faculty

  • Vaneeta Bamba, MD
    Faculty Reviewer

    Medical Director, Diagnostic and Research Growth Center
    Director, Turner Syndrome Program
    Associate Professor of Clinical Pediatrics
    Division of Endocrinology
    Perelman School of Medicine at the University of Pennsylvania
    Philadelphia, Pennsylvania

Learning Objectives

  • Implement shared decision-making to help patients select a somatropin product based on patient characteristics and needs and product labeling
  • Initiate, titrate and monitor somatropin in patients based on patient response and tolerability
  • Describe the safety and efficacy of emerging long-acting recombinant human growth hormone therapies and their potential use in clinical practice

Faculty Disclosures

Vaneeta Bamba, MD
Faculty Reviewer

Advisory Board: Novo Nordisk


Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Content Planners

Jessica Martin, PhD (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.